1 / 39

Fertility cryopreservation with oocyte vitrification

Fertility cryopreservation with oocyte vitrification. Ri-Cheng Chian, Ph.D. McGill Reproductive Center McGill University Health Center Department of Obstetrics and Gynecology McGill University, Montreal Canada. Female fertility using cryopreservation. Embryos - generated from IVF cycles;

lynde
Download Presentation

Fertility cryopreservation with oocyte vitrification

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Fertility cryopreservation with oocyte vitrification Ri-Cheng Chian, Ph.D. McGill Reproductive Center McGill University Health Center Department of Obstetrics and Gynecology McGill University, Montreal Canada

  2. Female fertility using cryopreservation • Embryos - generated from IVF cycles; • Ovarian tissues; • Eggs;

  3. Egg freezing • The development of an effective egg freezing system will have a significant impact on clinical practice of reproductive medicine; • Fertility preservation for young women requiring sterilizing medical and surgical treatments; • Cryobanking of eggs will benefit a large population of single women who wish to delay motherhood because of personal, professional and financial reason;

  4. Advantages of oocyte cryopreservation • Women without partners; • Avoids ethical issues and legal restrictions related to embryo banking; • Oocyte donation; • Option for delayed motherhood;

  5. Slow-freezing method for eggs: • The first live birth was reported by Chen (1986); • Over two decades, very few live births were reported; • Survival rate after thawing was approximately 50-55%; • Token together, less than 1,000 live births have been reported by the conventional slow-freezing method; • % of live births per thawed egg ranges from 1-10% using this protocols;

  6. Modified slow-freezing methods for eggs: • Increased sucrose concentration in suspending solution (0.2M or 0.3M respectively) (Yang et al., 1998; Fabbri et al., 2001; Chen et al., 2002; 2005); • Choline-based freezing medium to replace sodium (Stachecki et al., 1998; Quintans et al., 2002; Boldt et al., 2003); • The survival rate of the oocytes after thawing was increased to 65-70%;

  7. Vitrification method for eggs: • Kuleshova et al. (1999): Open pulled straw (Hum. Reprod., 14: 3077-3079); • Yoon et al. (2000; 2003): Electron microscope grid (Fertil. Steril., 74:180-181; Fertil. Steril., 79:1323-1326.); • Katayama et al. (2003): Cryotop (Fertil. Steril., 80: 223-224.); • The survival rate of the oocytes after thawing was approximately 85-90%;

  8. What is vitrification? • Vitrification is a process which allows glasslike solidication of water without ice-crystal formation in the living cells.

  9. History of vitrification • Luyet B. (1937): Working hypotheses on the nature of life. Biodynamica, 1:1-7. • Luyet B. (1937): The vitrification of organic colloids and protoplasm. Biodynamica, 1:7-14. • Fahy GM. (1981): Prospect for vitrification whole organs. Cryobiology, 18:617-625. • Rall WF and Fahy GM. (1985): Ice-free cryopreservation of mouse embryos at -196°C by vitrification. Nature, 313:573-575.

  10. Nature of water • The temperature below 0ºC will introduce formation of water ice-crystal; • Below -130ºC is the glass transition temperature of water;

  11. Cryobiology • Theoretically, if the formation of intracellular and extracellular ice-crystal prevented and the glass transition occurred, the cells will be survival after freezing-thawing; • However, the cells may have other injuries during freezing-thawing procedures;

  12. Cryobiology (cont.) • Chilling injury: • The temperature between +30ºC and 0ºC may compromise cell membrane integrity, metabolism and cytoskeleton; • Cryoprotectant may be required to add into freezing solution;

  13. CH3–S–CH3||O Cryoprotectants Glycerol Dimethylsulphoxide (DMSO) Propylene glycerol (PROH) Ethylene glycol (EG)

  14. Cryoprotectant (cont.) • The mechanism of the protective action of cryoprotectants is the same, but their toxicities are different; • Permeation ability is different with different cryoprotectants and temperatures; • Therefore, the toxicity of cryoprotectants must be considered for freezing;

  15. Cryoprotectant (cont.) • There are osmotic change before and after freezing in cryopreservation solution; • These osmotic changes may cause the death of cells, normally it is referred to ‘osmotic injury’;

  16. Cryoprotectant (cont.) • Hypertonic solution is required, i.e. sucrose is added to prevent swelling and shrinkage of the cells;

  17. Factors affect successful frozen-thawing • Chilling injury; • Cryoprotectant (toxicity and temperature); • Osmotic injury; • Speed of freezing and thawing;

  18. Is it difficult to freeze oocytes? • Mammalian oocytes have proven to be more difficult to cryopreserve than cleavage-stage embryos because it is relatively large cell and contains more water in the cell; • Mature oocytes with its special structures, like metaphase spindle is fragile for freezing;

  19. Vitrification procedure 7.5% EG+PROH 15.0%EG+PROH 0.5 sucrose EM (5 min) Loading onto McGill Cryoleaf Plunge into LN2(-196ºC) VM (1 min)

  20. Morphological change in EM and VM 1 min in EM 2 min in EM Before in EM 3 min in EM 4 min in EM 5 min in EM 10 sec in VM 30 sec in VM 1 min in VM

  21. McGill Cryoleaf

  22. Thawing procedure 1.0M sucrose 0.5M sucrose 0.25M sucrose Culture medium TM (37ºC) DM-I (3 min) DM-II (3 min) WM (3 min)

  23. Morphological changes in thawing media 0.5 min in TM 3.0 min in DM-1 3.0 min in DM-2 3.0 min in WM-1 3.0 min in WM-2 Transfer to culture

  24. Initial data for survival rates of human oocytes

  25. Immuno-fluorescent staining of meiotic spindles and chromosomes

  26. Aneuploidy screening of mouse oocytes following vitrification and slow-freezing

  27. Interpretation • Slow-freezing of oocytes results in more spindle and chromosome abnormalities than vitrification; • However, incidence of aneuploidy is similar between vitrification and slow freezing.

  28. Viability and pregnancy outcome of vitrified in-vivo oocytes following thawing and ICSI at McGill Reproductive Center Patients (cycles) 38 (38) Age 31.5 ± 0.5 No. of oocytes thawed 463 No. of oocytes survived (%) 383 (82.7) No. of oocytes fertilized (%) 287 (74.9) No. of embryos transferred 133 (3.5±1.1) No. of clinical pregnancies (%) 17 (44.7) No. of implantation (%) 25 (18.8) Chian et al (Fertil & Steril., In press)

  29. Clinical pregnancy outcome of vitrified in-vivo oocytes following thawing and ICSI at McGill Reproductive Center Patients (cycles) 38 (38) No. of clinical pregnancies (%) 17 (44.7) No. of live birth (%) 15 (39.5) No. of miscarriages 2 No. of singleton 9 No. of Twins 5 No. of triplets 1 No. of newborn 22 Chian et al (Fertil & Steril., In press)

  30. IVM-Vitrification trial at MRC Chian et al (Fertil & Steril., In press)

  31. Interpretation Pregnancies conceived following oocyte vitrification are not associated with adverse obstetric and perinatal outcomes.

  32. Conclusions • Vitrification of human oocytes is associated with acceptable pregnancy rate and normal obstetrical and neonatal outcomes; • The offspring derived from vitrified oocytes are healthy; • Vitrification of oocytes can be used safely for human reproductive medicine; • Oocyte vitrification may offer cancer patients for fertility preservation.

  33. Acknowledgements • Staff at McGill Reproductive Center; • Dr. Ruvalcaba Castellon, L.A. at Instituto Mexicano de Infertilidad, Jalisco, Mexico; • Dr. Lucena, E. at CECOLFES, Bogota, Colombia.

  34. Thank you! ri-cheng.chian@muhc.mcgill.ca

More Related